Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2013 Sep 6.

Published in final edited form as: Neurosci Lett. 2012 Jul 20;525(1):72–75. doi: 10.1016/j.neulet.2012.07.024

Fig. 1 — Lifespan of severe SMA mice with CNS administration of TC007 at p1 and p3 not significantly increased. (A) Kaplan-Meyer survival curve shown with TC007-treated SMA mice (solid black), and vehicle-treated SMA mice (dotted black). Arrows on X-axis indicates average lifespan of the SMA mice. (Mantel-Cox test p=0.1554; Vehicle-treated N=13, TC007-treated N=17) (B) Average lifespan of TC007-treated versus vehicle-treated SMA pups (Student’s T Test p=0.0846 and bars represent SEM).

Fig. 1 — Lifespan of severe SMA mice with CNS administration of TC007 at p1 and p3 not significantly increased. (A) Kaplan-Meyer survival curve shown with TC007-treated SMA mice (solid black), and vehicle-treated SMA mice (dotted black). Arrows on X-axis indicates average lifespan of the SMA mice. (Mantel-Cox test p=0.1554; Vehicle-treated N=13, TC007-treated N=17) (B) Average lifespan of TC007-treated versus vehicle-treated SMA pups (Student’s T Test p=0.0846 and bars represent SEM).